Study to Test the Accuracy of a Prototype Handheld PT/INR Device

Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant

NCT02079584 ·Status: COMPLETED

A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients

NCT00451412 ·Status: COMPLETED ·Phase: PHASE3

Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling

NCT01964794 ·Status: COMPLETED

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

NCT00365950 ·Status: COMPLETED ·Phase: PHASE4

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

NCT02704052 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

NCT03742336 ·Status: COMPLETED ·Phase: PHASE1

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4

Warfarin - How Good Are we at Maintaining Target Range ?

NCT01081327 ·Status: COMPLETED

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

NCT04117048 ·Status: COMPLETED ·Phase: NA

Dabigatran Versus Warfarin With NVAF Who Undergo PCI

NCT03536611 ·Status: UNKNOWN ·Phase: PHASE4

Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study

NCT01704053 ·Status: COMPLETED

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

NCT02376803 ·Status: COMPLETED ·Phase: PHASE4

Inpatient Monitoring of Unfractionated Heparin

NCT06329921 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)

NCT00933738 ·Status: COMPLETED

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4)

NCT01758432 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Upper Extremity Deep-Vein Thrombosis

NCT00245856 ·Status: COMPLETED ·Phase: PHASE4

A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants

NCT04208061 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)

NCT03473132 ·Status: UNKNOWN ·Phase: PHASE4

Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients

NCT00356759 ·Status: COMPLETED ·Phase: PHASE2

Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy

NCT00993200 ·Status: COMPLETED ·Phase: PHASE4

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

NCT00216866 ·Status: COMPLETED ·Phase: PHASE2

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

NCT01305148 ·Status: SUSPENDED ·Phase: NA

A Prospective Pharmacodynamic Study of Rivaroxaban

NCT01743898 ·Status: COMPLETED

Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management System

NCT00978445 ·Status: COMPLETED ·Phase: NA